vimarsana.com

Page 34 - அமெரிக்கன் கலைக்கழகம் ஆஃப் நரம்பியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Samsung Biologics Gets Expanded Contract to Make Ublituximab for MS

4.5 (2) TG Therapeutics has expanded its contract with Samsung Biologics to manufacture ublituximab, an investigational therapy for relapsing forms of multiple sclerosis (MS). “Samsung is the global leader in biologics manufacturing and we are happy to have them as our partner as we look forward to the potential commercialization of ublituximab across both oncology and autoimmune indications,” Michael S. Weiss, executive chairman and CEO of TG Therapeutics, said in a press release. Ublituximab is an antibody designed to prevent B-cells from triggering the inflammation that causes nerve cell damage in MS. It does so by targeting a protein called CD20 that’s found on the B-cell surface.

Alzheimer s disease prevalence variation between Spain, the US and Japan

Alzheimer’s disease prevalence variation between Spain, the US and Japan By GlobalData Healthcare 29 Apr 2021 (Last Updated May 19th, 2021 10:25) The global burden of dementia is rising. Worldwide, approximately 50 million individuals have dementia, of which Alzheimer s is most common, and there are nearly 10 million new cases each year, according to the World Health Organization (WHO). Share Article The global burden of dementia is rising. Worldwide, approximately 50 million individuals have dementia, of which Alzheimer’s disease (AD) is the most common, and there are nearly 10 million new cases each year, according to the World Health Organization (WHO). In recent years, evidence has shown that modifiable lifestyle behaviours can slow down brain degeneration and cognitive decline associated with AD. GlobalData examined the prevalence of AD in Spain and the ways in which the country’s lifestyle norms may

The Cloudy Role of Cannabis as a Neuropsychiatric Treatment

The Cloudy Role of Cannabis as a Neuropsychiatric Treatment
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

People With Neurological Conditions At Greater Risk of Death by COVID-19

People With Neurological Conditions At Greater Risk of Death by COVID-19 Elizabeth Gardner © (Getty Images) In Control Room Doctor and Radiologist Discuss Diagnosis while Watching Procedure and Monitors Showing Brain Scans Results, In the Background Patient Undergoes MRI or CT Scan Procedure. People who have been under the care of a neurologist, for anything from a stroke to Parkinson s disease to chronic migraines, have a substantially elevated risk of dying from COVID-19. That s the top takeaway from the largest study to date on the relationship between neurological problems and severe COVID-19 (the kind that puts people in the hospital). Such patients should take extra care to avoid COVID-19 infections, and should be vaccinated as soon as they can, says study author Sherry Chou, a critical care neurologist at the University of Pittsburgh Medical Center.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.